Until COVID-19 Disrupted our Lives, Alzheimer’s Disease Was Considered the Greatest Medical Challenge of the Century

Many different approaches have been offered by scientists to stem the overwhelming tide of Alzheimer’s disease (AD). Fifty percent of primary care physicians believe that the medical profession is not…

Continue Reading Until COVID-19 Disrupted our Lives, Alzheimer’s Disease Was Considered the Greatest Medical Challenge of the Century
A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started
source: pixabay.com

A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started

  Twins Iris and Clarisa Valdez recently shared their story of courage and hope and thanked the City of Hope care team for its guidance and support. But most importantly…

Continue Reading A Courageous Decision: The Valdez Twins Decided to Stop Cancer Before It Started
The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients
source: pixabay.com

The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients

As reported in BioSpace, the FDA shocked Mesoblast executives, a stem-cell research company, when this October, they rejected the Biologics License Application (BLA) for the drug Ryoncil, meant to treat…

Continue Reading The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients
A New Precision-Medicine Therapy for Duchenne Muscular Dystrophy Recently Approved by the FDA, Nearing Approval in Canada
source: pixabay.com

A New Precision-Medicine Therapy for Duchenne Muscular Dystrophy Recently Approved by the FDA, Nearing Approval in Canada

A new treatment for Duchenne muscular dystrophy (DMD) has recently been approved by the FDA. The therapy is called viltolarsen and it was created by Nippon-Shinyaku and the National Center…

Continue Reading A New Precision-Medicine Therapy for Duchenne Muscular Dystrophy Recently Approved by the FDA, Nearing Approval in Canada
New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen
source: pixabay.com

New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen

A recent study has found a 12.5% improvement for patients with severe COVID-19 when baricitinib was used in combination with remdesivir. That means a faster recovery time for patients and…

Continue Reading New Study Finds Remdesivir in Combination with Baricitinib is More Effective for COVID-19 Patients Requiring Oxygen
Intellia Authorized to Begin NTLA-2001 Trial for hATTR
3dman_eu / Pixabay

Intellia Authorized to Begin NTLA-2001 Trial for hATTR

In a recent press release, genome editing company Intellia Therapeutics, Inc. ("Intellia") announced its recent MHRA authorization to begin a Phase 1 clinical trial to evaluate its therapeutic candidate NTLA-2001. The…

Continue Reading Intellia Authorized to Begin NTLA-2001 Trial for hATTR